Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,762 public trials 1,061 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

NCT00052910

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 535 locations
View Trial Details
Completed

Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

NCT01440270

Conditions
Head and Neck Neoplasms, Locally Advanced Malignant Neoplasm, Mouth Diseases, +11 more
Locations
  • Eye & Ear Hospital of Fudan University Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China
  • Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology

NCT00784303

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations
  • Little Rock, Arkansas, United States
  • Los Angeles, California, United States
  • Los Gatos, California, United States
  • Mission Viejo, California, United States
View all 42 locations
View Trial Details

Related conditions